Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Profit After Tax (2016 - 2025)

iBio (IBIO) has disclosed Profit After Tax for 16 consecutive years, with -$9.0 million as the latest value for Q4 2025.

  • Quarterly Profit After Tax fell 106.07% to -$9.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$24.7 million through Dec 2025, down 67.47% year-over-year, with the annual reading at -$18.4 million for FY2025, 19.0% down from the prior year.
  • Profit After Tax for Q4 2025 was -$9.0 million at iBio, down from -$5.7 million in the prior quarter.
  • The five-year high for Profit After Tax was $114000.0 in Q2 2021, with the low at -$33.6 million in Q4 2022.
  • Average Profit After Tax over 5 years is -$7.9 million, with a median of -$6.0 million recorded in 2023.
  • The sharpest move saw Profit After Tax skyrocketed 103.22% in 2021, then tumbled 9211.4% in 2022.
  • Over 5 years, Profit After Tax stood at -$7.2 million in 2021, then plummeted by 366.6% to -$33.6 million in 2022, then skyrocketed by 75.53% to -$8.2 million in 2023, then surged by 46.85% to -$4.4 million in 2024, then crashed by 106.07% to -$9.0 million in 2025.
  • According to Business Quant data, Profit After Tax over the past three periods came in at -$9.0 million, -$5.7 million, and -$5.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.